Research

Hormonal

In patients with Type 2 Diabetes Mellitus, paracrine signaling in the adult muscle stem cell niche is activated, specifically through the upregulation of the PDGF–miR-501 pathway.

This research identifies a specific molecular pathway (PDGF-miR-501) that is overactive in the muscle stem cell niche of people with Type 2 Diabetes. This activation might contribute to muscle health issues. While this paper doesn't offer a treatment, it highlights a potential target for future therapies aimed at restoring normal signaling in the muscle niche to improve muscle health in diabetic patients.

GoodSupportsHIGH confidence
We conclude that paracrine signaling in the adult muscle stem cell niche is activated in T2D. Skeletal muscle biopsies from patients with T2D revealed upregulation of PDGF (1.62-fold, P = .002), CLCN5-2 (2.85-fold, P = .03), and miR-501 (1.73-fold, P = .02) compared with normoglycemic controls.
Alexandra Fahrner et al. · The Journal of Clinical Endocrinology & Metabolism · 2023

Why this rating

The study uses human muscle biopsies from a controlled cohort (7 T2D vs 7 controls) with statistically significant results (P < .05) and corroborating mouse model data.

Source

Activation of PDGF Signaling in the Adult Muscle Stem Cell Niche in Patients With Type 2 Diabetes Mellitus

Alexandra Fahrner et al. · The Journal of Clinical Endocrinology & Metabolism · 2023

DOI 10.1210/clinem/dgad041

mechanism_only · n=46Cited 2×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →